Hypertension is a complex disorder influenced by genetic and environmental determinants and their interactions. The objectives of the Genetic Epidemiology Network of Salt Sensitivity (GenSalt) are to localize and identify genes related to blood pressure (BP) responses to dietary sodium and potassium intervention. GenSalt utilizes a family feeding-study design. Each family was ascertained through a proband with untreated prehypertension or stage-1 hypertension in rural China. A medical history, lifestyle risk factors and responses to cold pressor tests, were obtained at baseline visits while BP, weight, blood and urine specimens were collected at baseline and follow-up visits. The dietary intervention included a 7-day low-sodium feeding (51.3 mmol/day), a 7-day high-sodium feeding (307.8 mmol/day) and a 7-day high-sodium feeding with an oral potassium supplementation (60 mmol/day). Microsatellite markers for genome-wide linkage scan and single nucleotide polymorphism (SNP) markers in candidate genes will be genotyped. Overall, 3153 participants from 658 families were recruited for GenSalt. The mean systolic and diastolic BPs were 128.0 and 80.3, 111.6 and 71.0, 112.6 and 72.6, 106.6 and 65.3 and 136.7 
Introduction
Hypertension is a global public health challenge because of its high prevalence and the concomitant increase in risk of cardiovascular and kidney diseases. 1 Epidemiologic studies and clinical trials have documented that weight loss, exercise, alcohol restriction, sodium reduction and potassium supplementation reduce blood pressure (BP) in both hypertensive and normotensive persons.
2 BP reduction in response to these lifestyle modifications, however, varies considerably among individuals. For instance, it has been suggested that BP response to dietary sodium intake varies among individualsa phenomenon described as salt sensitivity -and the heterogeneity of this effect is far from being completely understood. 3, 4 Genetic predisposition might play an important role in determining individual susceptibility to dietary sodium intake. 5, 6 The Genetic Epidemiology Network of Salt Sensitivity (GenSalt) utilizes a family feeding-study design to examine gene-diet (sodium and potassium) interactions on BP. The overall objective of the GenSalt study is to identify susceptibility genes that influence individual BP responses to dietary sodium and potassium intake in human populations. The specific aims are (1) to localize and identify novel genes related to variation in BP responses to a low dietary sodium intake and a high dietary sodium intake, (2) to localize and identify novel genes related to variations in BP responses to oral potassium supplementation and (3) to localize and identify novel genes related to BP responses to a cold pressor test. In addition, the GenSalt study will localize and identify genes related to usual BP level and the risk of hypertension.
Methods

Study population
The GenSalt study participants were recruited from six field-centres in Hebei, Henan, Shandong (two sites), Shaanxi and Jiangsu provinces in rural north China ( Figure 1 ). The selection of these study sites was based on homogeneity of the study population regarding their ethnicity and environmental exposures, including lifestyle and nutritional factors and habitual dietary intake of high salt and low potassium. The residents in these regions are of Han nationality, the ethnic majority in China.
The GenSalt sampling design targets families at high risk for developing hypertension, who may be sensitive to sodium and potassium interventions. The eligibility criteria for the probands and siblings/ offspring are listed in Table 1 . A community-based BP screen was conducted among all residents aged 18-60 years in the study villages to identify potential probands for the study. Those with mean systolic BPX130 mm Hg and/or diastolic BPX85 mm Hg had a second BP screening visit 1 day later to confirm their eligibility. A brief medical questionnaire including history of hypertension and use of antihypertensive medications was administered. After probands and their siblings were confirmed for eligibility, they were invited to participate in the study and signed an informed consent form. If multiple persons met the criteria as proband within a family, they were all included in the study. Both two-generation (proband, siblings and their parents) and three-generation families (proband, siblings, their parents, proband's spouse and offspring) were recruited for the study. Only probands, siblings, offspring and spouses of probands from three-generation families participated in the dietary intervention. The rationale for this design was that siblings provide the most useful information for linkage analyses between genetic markers and BP response to intervention. 7 Genotypic information in parents will be used for estimating identical by decent as well as for the transmission/disequilibrium test (TDT).
Intervention
The dietary intervention included low-sodium, high-sodium and high-potassium feeding among probands and their siblings and offspring ( Figure 2 ). In the first 3 days at the baseline observation, the study participants consumed their usual diet. On day 2 or 3, a cold pressor test was conducted among all study participants. BP response to cold pressor has been related to sodium sensitivity and predicts the risk of hypertension. 8, 9 The dietary feeding study started on day 4. The intervention participants received a low-sodium diet (3 g of salt or 51.3 mmol of sodium/day) for 7 days (days 4-10). Then, they received a high-sodium diet (18 g of salt or 307.8 mmol of sodium per day) for 7 days (days [11] [12] [13] [14] [15] [16] [17] . During the first two intervention phases, potassium intake remained unchanged. In the final week (days [18] [19] [20] [21] [22] [23] [24] , the participants maintained a high-sodium diet and took a 60 mmol of potassium supplement. All foods and beverages were prepared by study dietitians and provided by the study staff. The study participants came to the study kitchen for their breakfast, lunch and dinner during the entire intervention period. All foods were cooked without salt and prepackaged salt was added to the individual study participant's meal when it was served by the study staff. Although dietary salt intake was the same for all study participants, dietary total energy intake was varied into five levels (1600, 2100, 2600, 3100 and 3600 kcal/day) according to their baseline energy intake assessed by a brief food frequency questionnaire.
Phenotype measures
Phenotypic data collection at the baseline examination and during intervention are summarized in Table 2 . A standard questionnaire was administered by trained staff at the baseline examination to collect information on demographic characteristics, family pedigree, personal and family medical history and lifestyle risk factors.
BP measurements. Three BP measurements were obtained at each clinical visit by trained and certified observers according to a common protocol adapted from procedures recommended by the American Heart Association. 10 BP was measured with the participant in the sitting position after 5 min of rest. In addition, participants were advised to avoid alcohol, cigarette smoking, coffee/tea and exercise for at least 30 min before their BP measurement. A random-zero sphygmomanometer was used, and one of the four cuff sizes (paediatric, regular adult, large or thigh) was chosen on the basis of the circumference of the participant's arm. 10 BP was measured in the morning of the 3-day baseline observation, and on days 2, 5, 6 and 7 of each intervention period by the same BP technician using the same sphygmomanometer to avoid observation variation. Blood analyses Blood sample collected at baseline and each intervention phase to measure renin activity, angiotensin converting enzyme, atrial natriuretic peptide, insulin, glucose and lipids
Urine analyses
One 24 h and two 8 h overnight urine collections at baseline and each intervention phase to measure sodium, potassium and creatinine Abbreviation: BP, blood pressure.
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The GenSalt Collaborative Research Group the participant had remained seated for 20 min, three BP measurements were obtained using a standard mercury sphygmomanometer before the ice water immersion. Then, the participant immersed their left hand in the ice water bath (3-51C) to just above the wrist for 1 min. BP measurements at 0, 60, 120 and 240 s were obtained on the right arm using a standard mercury sphygmomanometer after the left hand had been removed from the ice water bath.
Laboratory measurements. Overnight fasting blood samples were drawn by venipuncture at the baseline examination (day 1) and at each of the intervention periods (day 6 of each phase). Blood specimens were processed at the field centre and immediately frozen until they were shipped to the central clinical laboratory in Beijing. Total cholesterol, high density lipoprotein (HDL)-cholesterol and triglycerides were analyzed enzymatically using commercially available reagents. 11 Low density lipoprotein (LDL)-cholesterol levels were calculated using the Friedewald equation for participants who had triglyceride levels o400 mg/dl: LDL cholesterol ¼ total cholesterolÀHDL-cholesterolÀtriglyceride/5.
12 Plasma glucose was measured using a modified hexokinase enzymatic method. Serum creatinine was measured by the modified kinetic Jaffe reaction method. 13 One 24 h and two timed-overnight urinary specimens were collected at the baseline examination and on the last 3 days of each intervention period to measure sodium and potassium levels.
Genomic studies
Lymphocyte DNA samples were obtained from GenSalt family members and will be used for genotyping microsatellite markers spaced at approximately 10 cM intervals (407 markers, Marshfield Screening Set 12). Microsatellite genotyping uses fluorescently labelled PCR primers for marker amplification followed by capillary electrophoresis on automated DNA sequencers (ABI 3730 DNA Analyzer, Applied Biosystems, Foster City, USA). Quality control samples include blind duplicates, no DNA controls and CEPH DNA standards (mother, father, offspring with known genotypes). Genotypes are assigned using GeneMapper software (ABI) and tested for consistency with known relationships among GenSalt pedigrees.
GenSalt lymphocyte DNA samples will also be used to genotype single nucleotide polymorphisms (SNPs) in candidate genes involved in pathways related to BP regulation. The initial section of candidate genes has been focused on the reninangiotensin-aldosterone system. The SNPs were chosen based on linkage disequilibrium (LD) structure in the Chinese population as determined by the International HapMap Project.
14 SNP genotyping uses SNPlex assays (Applied Biosystems) based on oligonucleotide ligation assay for capillary electrophoresis on an automated DNA Sequencer (ABI 3700 DNA Analyzer, Applied Biosystems).
Data analysis
Linkage and association analyses constitute the primary analysis of intervention data (measured gene methods). However, familial correlations, path and segregation analyses (unmeasured gene methods) will also be used because they provide valuable information for motivating and interpreting the genomic analyses. The unmeasured gene methods are designed to screen the BP responses for evidence of heritability and the patterns of familial transmission.
Genome-wide linkage analysis will be utilized to discover new and verify known genomic regions using both parametric and nonparametric methods. Parametric methods are generally more powerful when good information is available on the mode of inheritance (e.g., allele frequencies, genotype means and so on), which may be derived from the literature or using segregation analysis. However, when this information is uncertain, model-free linkage analysis is preferred.
A variety of methods will be used to explore the associations between candidate gene SNPs and the BP responses. For example, LD information among the multiple tightly linked SNP markers can be used in haplotype analysis. 15, 16 To control for possible population admixture, we will take advantage of parental genotypic data and perform TDT 17 using conventional methods developed for analyzing genetic associations in sibships. We will use TDT extensions that allow for sibships of various sizes, 18 for nuclear family 19, 20 and extended pedigree data 21 and for quantitative traits through the framework of multivariate regression 22, 23 or variance components analysis, 24 and incorporate gene-by-environment and gene-by-gene interactions. 25 In addition to using the candidate gene SNP panel that will be typed, these analyses may also be carried out on selected markers showing novel signals from the linkage marker panel with the hope of detecting new positional candidates and forming the basis for further gene-wide dense SNP scans. The issue of multiple testing will be explored using several methodologies including permutation tests which use empirical methods to evaluate how often a given P-value would arise by chance if the study were repeated without any associations. 26 Quality assurance and quality control All study staff successfully completed a training programme that oriented them both to the aims of the study and to the specific tools and methodologies employed. At the training sessions, interviewers were given detailed instructions on administration of the study questionnaire. All BP observers participated in a special training session on the use of a standardized protocol for measurement of BP. Satisfactory performance during a written test on knowledge of preparing study participants for BP measurement, selecting correct cuff size and using standard techniques for BP measurement during a standardized videotape examination and during concordant measurements of BP with an instructor were required for certification as a GenSalt BP observer. All BP observers were blinded to the dietary intervention.
To ensure study participants' compliance to the intervention programme, they were required to have their breakfast, lunch and dinner at the study kitchen under supervision of the study staff during the entire study period. The food consumption of study participants was carefully recorded at each meal by the study staff. In addition, timed urinary specimens were collected to monitor participants' compliance to dietary sodium and potassium intake. The GenSalt clinical and genomic laboratories follow rigorous quality assurance and quality control programmes, which includes randomly selecting 5% duplicate samples to assess the test-retest reliability of all key laboratory measurements. Regular site visits to the field centre and laboratories are conducted by the study and data coordinating centre.
All study forms were checked for completeness and entered into a computer database in the field. A second data entry was independently conducted at the coordinating centre in Beijing. All data were transferred to the data centre in the United States via secured internet where they were checked for discrepancies between the two data entries as well as illogical entries. Lists of discrepancies and illogical data were sent back to field centres to verify the values against original records. Errors were corrected according to original data or additional follow-up with study participants.
The Institutional Review Board at all participating institutes approved the GenSalt study. In addition, the National Human Genomic Resource Administration of China approved the study. Written informed consents for the baseline observation and for the intervention were obtained from each participant before data collection and intervention, respectively.
Results
Recruitment and intervention began in October 2003
and were completed by July 2005. Overall, 3153 study participants from 658 families were enrolled in the study. Of these, 564 are two-generation and 94 are three-generation families. A total of 1906 study participants (676 probands, 956 siblings, 69 spouses and 205 offspring) took part in the dietary intervention. Among them, 1879 (98.6%) completed the entire 21-day dietary intervention.
The completeness of study questionnaire data, BP and anthropometric data, blood and urinary sample collection was nearly 100%. Based on data from 332 repeated measures, the reliability (intra-class correlation between original and corresponding phantom samples) is 0.97 for serum total cholesterol, 0.98 for HDL-cholesterol, 1.00 for triglycerides, 0.97 for plasma glucose and 0.91 for serum creatinine. In addition, the reliability for urinary sodium and potassium measurements is 0.99 and 0.98, respectively, according to data from 1141 repeated measures.
Baseline characteristics of study participants are presented in Table 3 . On average, probands were 41 years old, 60.4% male, and had a mean body mass index (BMI) of 24.2 kg/m 2 , mean systolic BP of 128.0 mm Hg and mean diastolic BP of 80.3 mm Hg. As a whole, the study participants were on average 50 years old, 51% male, 29% were current cigarette smokers, 27% were alcohol drinkers, 17% selfreported hypertension and 1% self-reported diabetes. They were engaged in heavy physical labour with a mean MET of 56.6 per week. The mean BMI was 23.1 kg/m 2 , systolic BP 124.7 mm Hg and diastolic BP 74.3 mm Hg among the entire study population. The average urinary 24-h excretion of sodium was 224.3 mmol/l and the urinary 24-h excretion of potassium was 38.1 mmol/l in this study population.
The maximum BP responses to cold pressor test, as well as BP measurements at 0, 60, 120 and 240 s after the end of immersion are shown in Table 4 . The mean of the maximum BP response to cold pressor was 13.9 mm Hg for systolic BP and 7.7 mm Hg for diastolic BP. The distribution of the maximum BP responses was slightly right-skewed (Figure 3 ).
Discussion
Hypertension is a complex disease influenced by multiple genes and environmental risk factors as well as their interactions. Failure to consider such interactions may result in the inability to detect or accurately quantify the underlying genetic contribution to BP variability. The difficulty of measuring individual habitual dietary intake of sodium and potassium has been well documented. 27 In the GenSalt study, we were able to control sodium and potassium intake among the intervention study participants over the entire intervention period. In addition, we were able to expose the study participants to extreme changes in sodium and potassium intake that may be necessary to unmask variation in BP responses to these electrolytes. Therefore, the proposed study should have a good probability to identify genes determining individual BP responses to sodium and potassium intake.
Kawasaki et al. 3 and later on Weinberger et al. were among the first to recognize the heterogeneity of BP response to sodium intake and to develop the concept of salt sensitivity in humans. The definition of salt sensitivity has varied between studies, mostly being defined as a proportional change (i.e., X3 to X10%) or an absolute change (i.e., X3 to X10 mm Hg) in mean arterial BP. Despite the variety of the definitions and protocols used to test for salt sensitivity, several findings have been consistently observed. 3, 4, 28 First, salt-induced changes in BP are normally distributed in populations and there is no evidence for a bimodal distribution. Like defining hypertension, using a cut point to categorize subjects into salt-sensitive and nonsensitive is arbitrary. Second, salt sensitivity is a common biological phenomenon in human populations. Depending on the definition and measurement methods, salt sensitivity has been noted in 25-50% of normotensives and 40-75% of hypertensive patients. In addition, the prevalence of salt sensitivity is increased among individuals who are older, overweight, with a family history of hypertension or of African-American descent. 4 Recent prospective cohort studies have also indicated that salt sensitivity is a strong predictor for CVD and total mortality in hypertensive and normotensive participants. 29, 30 Our study design has several strengths. Use of the family study design avoids the confounding effect of population stratification. Furthermore, the primary advantage of our family study design is the ability to localize novel genes related to BP responses to dietary sodium and potassium interventions, through a genome-wide linkage scan as well as testing candidate genes. Our study was conducted in a rural area in north China with several unique features: (1) multiple generations of family members tend to live in the same villages in the study areas, which facilitates the recruitment and intervention processes; (2) relative genetic homogeneity in the study regions has been preserved; (3) population stratification is distinct; (4) rural residents have similar environmental exposures (including diet); and (5) data collection and intervention are costeffective.
Establishing a relationship between genetic variants with salt sensitivity will help identify individuals at high risk for hypertension and who should receive a low-sodium dietary intervention or pharmaceutical treatment using novel genotype-based drugs. In addition, identifying genes that influence significantly the effect of dietary sodium intake on the regulation of BP will contribute significantly to the knowledge about underlying physiological pathways to hypertension. Identifying genetic variants associated with salt-sensitive hypertension will also assist in the development of new antihypertensive medications targeting biological pathways related to sodium metabolites. The findings from this study could significantly contribute to the effectiveness of clinical patient care and population-wide prevention of salt-sensitive hypertension. pressor stress and its relation to sodium metabolism in salt-sensitive children. Chin Med J 1997; 77: 583-585. 9 Kasagi F, Akahoshi M, Shimaoka K. Relation between cold pressor test and development of hypertension What is known about this topic: K Epidemiologic studies and clinical trials have documented that a high dietary sodium and low potassium intake increases BP. K BP response to dietary sodium intake varies among individuals -a phenomenon described as salt sensitivityand the reason for this heterogeneous response is far from being completely understood.
What this study adds: K This manuscript describes the study design and participant baseline characteristics of a family-feeding study aimed at identifying novel genes related to variation in BP responses to dietary sodium and potassium intakes.
Abbreviation: BP, blood pressure.
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